Skip to main content
. Author manuscript; available in PMC: 2018 Dec 1.
Published in final edited form as: J Rheumatol. 2017 Sep 1;44(12):1933–1937. doi: 10.3899/jrheum.161467

Figure 1.

Figure 1

A draft core set (domains requiring some representation by a outcome measures in all trials) and additional preferred domains i) common to both giant cell arteritis (GCA) and Takayasu’s arteritis (TAK), and ii) separate disease-specific domains. The suggested core domains fall under the mandatory core areas of OMERACT filter 2.0: *Death, ‡life impact, and †pathophysiologic manifestations.